Efficacy and safety of esmethadone and rapastinel for major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.

M A Muneer; Q U Ain; S Zahid; O Farooq; M Talha; M Waqas; F Amin; M A Tawab; F A Jabbar; H M Jafri; A Aala; S T Haider

doi:10.12809/eaap2664

SCHEDA SCIENTIFICA2026Metanalisi

Efficacy and safety of esmethadone and rapastinel for major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.

M A Muneer, Q U Ain, S Zahid, O Farooq, M Talha, M Waqas, F Amin, M A Tawab, F A Jabbar, H M Jafri, A Aala, S T Haider

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan · 2026

Psicologia clinica Psicoterapia Psicopatologia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansMajor Depressive DisorderRandomized Controlled Trials as TopicOligopeptidesMethadoneGLYX-13 peptideMajor depressive disorderMeta-analysisReceptors, N-methyl-D-aspartate

Come citare questo studio

M A Muneer, Q U Ain, S Zahid, O Farooq, M Talha, M Waqas, F Amin, M A Tawab, F A Jabbar, H M Jafri, A Aala, S T Haider. (2026). Efficacy and safety of esmethadone and rapastinel for major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan. DOI: 10.12809/eaap2664

Consulta la pubblicazione originale ↗